← all works
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet
- Topic
- Heart Failure Treatment and Management
- Field
- Medicine
- Canadian institutions
- Hamilton General Hospital
- Funders
- AstraZeneca
- Keywords
- CandesartanEjection fractionMedicineHeart failureCardiologyInternal medicineHazard ratioPlaceboMyocardial infarctionStroke (engine)Angiotensin IIACE inhibitorAngiotensin-converting enzymeConfidence intervalBlood pressure
- Has abstract in OpenAlex
- no